V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003662 | 330001863 | 1.88 | 76.7 | Neo-adjuvant (N) | 2016-11-12 | 2016-11-12 | EW EuroEwing 99 : VIDE | N | N | 330013331 | EURO-EWING |
| 330003663 | 330001864 | 1.76 | 64.5 | Neo-adjuvant (N) | 2015-07-27 | 2015-07-27 | Dox + HD Mtx (post PAM) | N | N | 330013345 | DOXORUBICIN + HD MTX |
| 330003664 | 330001864 | 1.52 | 51.6 | Palliative (P) | null | 2017-01-20 | CISPLATIN + GEMCITABINE | null | null | 330013345 | CISPLATIN + GEMCITABINE |
| 330003665 | 330001865 | 1.68 | null | Neo-adjuvant (N) | 2014-11-28 | 2014-11-30 | OST Euramos 1 Closed Trial - AP | null | N | 330013348 | MAP |
| 330003667 | 330007006 | 1.88 | 61.5 | Neo-adjuvant (N) | 2013-08-12 | 2013-08-18 | MAP | N | N | 330013372 | MAP |
| 330003668 | 330007006 | 1.62 | 49.2 | Neo-adjuvant (N) | 2015-01-28 | 2015-01-28 | Dox + HD Mtx (post PAM) | 02 | N | 330013372 | DOXORUBICIN + HD MTX |
| 330003669 | 330007006 | 1.67 | 96.5 | Palliative (P) | 2015-09-18 | 2015-11-13 | GemCarbo Days 1+8 | null | Y | 330013372 | GEMCARBO |
| 330003670 | 330012184 | 1.77 | 60.5 | Neo-adjuvant (N) | 2016-12-06 | 2016-12-08 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330013386 | CARBO + FLUOROURACIL |
| 330003671 | 330012184 | 1.81 | 97.7 | Curative (C) | 2017-02-03 | 2017-02-09 | EW EuroEwing 99 : VActI | N | N | 330013386 | EURO-EWING |
| 330003672 | 330001867 | 1.81 | 66 | Palliative (P) | 2017-07-11 | 2017-07-14 | GEMCARBO | 02 | null | 330013393 | GEMCARBO |
| 330003673 | 330001867 | 1.67 | 72.5 | Palliative (P) | 2016-10-26 | 2016-11-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330013393 | CISPLATIN + GEMCITABINE |
| 330003677 | 330001868 | 1.68 | 62.5 | Curative (C) | null | 2014-01-29 | EW EuroEwing 2012 Arm A VIDE | N | Y | 330013421 | EURO-EWING |
| 330003678 | 330001868 | 1.74 | 57.4 | Neo-adjuvant (N) | 2014-04-16 | 2014-04-18 | CISPLATIN + GEMCITABINE | N | N | 330013421 | CISPLATIN + GEMCITABINE |
| 330003679 | 330001868 | 1.76 | 63.4 | Curative (C) | 2015-12-08 | 2015-12-15 | EURAMOS TRIAL | null | null | 330013421 | EURAMOS TRIAL |
| 330003680 | 330001868 | 1.75 | 80.9 | Palliative (P) | 2017-02-01 | 2017-02-13 | CVP R | N | N | 330013421 | CVP R |
| 330003681 | 330001868 | 1.66 | 63 | Neo-adjuvant (N) | 2014-07-25 | 2014-07-29 | Dox + HD Mtx (post PAM) | 02 | N | 330013421 | DOXORUBICIN + HD MTX |
| 330003682 | 330001869 | 1.56 | 54 | Not known (9) | 2015-05-06 | 2015-05-29 | CETUXIMAB + RT | N | Y | 330013481 | CETUXIMAB + RT |
| 330003683 | 330001870 | 1.57 | 64.6 | Neo-adjuvant (N) | 2018-04-11 | 2018-04-20 | GemCarbo Days 1+8 | Y | N | 330013482 | GEMCARBO |
| 330003685 | 330001872 | null | 56.6 | Curative (C) | 2013-05-16 | 2013-06-01 | Cetuximab + Radiotherapy Maint | N | null | 330013487 | CETUXIMAB + RT |
| 330003686 | 330007009 | 0 | null | Palliative (P) | 2017-01-15 | 2017-02-02 | CVP R | N | N | 330013489 | CVP R |
| 330003687 | 330007009 | 1.65 | 63.6 | Neo-adjuvant (N) | 2015-06-03 | 2015-06-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330013489 | CISPLATIN + GEMCITABINE |
| 330003694 | 330001874 | 1.68 | 60.8 | Neo-adjuvant (N) | 2015-01-13 | 2015-01-18 | CAP | 02 | N | 330013546 | CAP |
| 330003695 | 330007011 | 1.77 | 61 | Curative (C) | 2015-02-17 | 2015-02-22 | Cetuximab 7 day (>Cycle 2) | N | Y | 330013548 | CETUXIMAB |
| 330003696 | 330007011 | 1.64 | 52.5 | Neo-adjuvant (N) | 2015-05-18 | 2015-05-20 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330013548 | EURO-EWING |
| 330003701 | 330001875 | 1.8 | 24.4 | Palliative (P) | 2016-12-11 | 2017-01-04 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 330013591 | CARBO + FLUOROURACIL |
| 330003702 | 330001876 | 1.66 | 79 | Curative (C) | null | 2013-05-21 | EURAMOS TRIAL | 02 | null | 330013595 | EURAMOS TRIAL |
| 330003703 | 330001876 | 1.6 | 79 | Palliative (P) | 2014-02-28 | 2014-02-28 | CVP R | 02 | N | 330013595 | CVP R |
| 330003704 | 330001876 | 1.91 | null | Disease modification (D) | 2015-06-11 | 2015-06-12 | CVP R | Y | null | 330013595 | CVP R |
| 330003705 | 330001876 | 0 | 64.6 | Adjuvant (A) | 2013-04-06 | 2013-04-17 | OST Euramos 1 Closed Trial - AP | Y | N | 330013595 | MAP |
| 330003708 | 330009790 | 1.79 | 85 | Curative (C) | 2013-11-20 | 2013-11-27 | EW EuroEwing 99 : VIDE | null | N | 330013675 | EURO-EWING |
| 330003709 | 330009790 | 1.88 | 36 | Curative (C) | 2013-05-21 | 2013-05-21 | Cyclophosphamide + Dex + Rituximab | N | N | 330013675 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003711 | 330001879 | null | 75.1 | Palliative (P) | 2014-07-23 | 2014-07-28 | GemCarbo Days 1+8 | N | N | 330013691 | GEMCARBO |
| 330003712 | 330001879 | 1.81 | 74.8 | Adjuvant (A) | null | 2016-06-04 | Cetuximab + Radiotherapy Load | null | null | 330013691 | CETUXIMAB + RT |
| 330003713 | 330001879 | 1.73 | 49 | Not known (9) | 2014-07-05 | 2014-07-09 | Carbo F | 02 | null | 330013691 | CARBO + FLUOROURACIL |
| 330003714 | 330001879 | 0 | 79.6 | Palliative (P) | 2017-02-08 | 2017-02-16 | GemCarbo Days 1+8 | Y | N | 330013691 | GEMCARBO |
| 330003715 | 330001879 | 1.72 | 51.6 | Palliative (P) | 2017-07-27 | 2017-07-27 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 330013691 | CISPLATIN + GEMCITABINE |
| 330003716 | 330001879 | 1.81 | 67.8 | Disease modification (D) | 2016-01-19 | 2016-01-19 | Cyclophosphamide + Dex + Rituximab | N | N | 330013691 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003718 | 330007015 | 1.43 | 21.1 | Neo-adjuvant (N) | 2013-02-10 | 2013-02-19 | Cisplatin + Etoposide po&iv 3 day | Y | N | 330013724 | CISPLATIN + ETOPOSIDE |
| 330003719 | 330007015 | 1.74 | 58.9 | Disease modification (D) | 2013-05-29 | 2013-06-04 | CVP R | N | N | 330013724 | CVP R |
| 330003720 | 330007015 | null | 12.9 | Disease modification (D) | 2015-02-07 | 2015-02-25 | DA 3 + 10 | N | N | 330013724 | DA |
| 330003721 | 330001881 | 1.62 | 86.1 | Curative (C) | 2017-03-02 | 2017-03-20 | Cetuximab 7 day (>Cycle 2) | N | Y | 330013738 | CETUXIMAB |
| 330003722 | 330001881 | 1.67 | 96.5 | Palliative (P) | 2016-06-04 | 2016-06-17 | Cisplatin + Etoposide po&iv 3 day | 2 | N | 330013738 | CISPLATIN + ETOPOSIDE |
| 330003723 | 330001881 | null | null | Adjuvant (A) | 2016-06-05 | 2016-06-16 | CARBOPLATIN + FLUOROURACIL | N | N | 330013738 | CARBO + FLUOROURACIL |
| 330003724 | 330001882 | 1.68 | 69.3 | Neo-adjuvant (N) | null | 2016-08-03 | Dox + HD Mtx (post PAM) | N | N | 330013763 | DOXORUBICIN + HD MTX |
| 330003725 | 330001883 | 1.57 | 151.7 | Curative (C) | 2016-10-31 | 2016-11-10 | CARBOPLATIN + FLUOROURACIL | N | N | 330013765 | CARBO + FLUOROURACIL |
| 330003726 | 330001883 | null | 61 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-21 | Carbo F | 02 | N | 330013765 | CARBO + FLUOROURACIL |
| 330003727 | 330001883 | 0 | 74.4 | Curative (C) | null | 2017-05-24 | Cetuximab + Radiotherapy Load | null | null | 330013765 | CETUXIMAB + RT |
| 330003728 | 330001884 | 0 | 63.4 | Adjuvant (A) | 2017-11-08 | 2017-11-14 | EW EuroEwing 2012 Arm A VIDE | N | N | 330013778 | EURO-EWING |
| 330003729 | 330001885 | 1.37 | 76.3 | Neo-adjuvant (N) | 2013-07-13 | 2013-07-22 | PAM | N | N | 330013781 | MAP |
| 330003730 | 330001885 | 1.48 | 56 | Palliative (P) | 2014-07-14 | 2014-07-14 | Cetuximab 7 day (Cycle 1) | N | Y | 330013781 | CETUXIMAB |